Cardinal Health's drug sales boost overall revenue in Q3

By Michael Sandler  |  April 28, 2016

Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.

Kaiser Permanente drops $525 million contract with Owens & Minor

By Adam Rubenfire  |  April 20, 2016

Kaiser Permanente has dropped its $525 million contract with Owens & Minor for medical-surgical supply distribution, marking the second time that the supplier has reported a major contract loss in less than a year.

FDA compounding enforcement draws ire from Congress

By Adam Rubenfire  |  April 19, 2016

A House committee says the Food and Drug Administration's regulation of drug compounding is veering from the intent of the law passed in 2013 in the wake of a national meningitis outbreak tied to unsanitary practices at a compounding pharmacy.

FDA clarifies compounding rules

FDA clarifies compounding rules

By Adam Rubenfire  |  April 15, 2016

The proposed rules clarify the amount of drugs that providers can compound without a prescription, set requirements for health system compounding pharmacies and clarify how large-scale compounding sites known as “outsourcing facilities” may be set up.

Bristol-Myers Squibb donates hep C drugs to developing countries

By Adam Rubenfire  |  April 14, 2016

The New York-based pharma giant announced Thursday that it will immediately begin providing enough Daklinza to treat 10,000 patients over the next two years. Bristol-Myers will provide drugs for patients in Ethiopia, Myanmar, Nigeria, Rwanda and Vietnam.

Former Pfizer CEO Henry McKinnell Jr. joins ViewRay's board

Former Pfizer CEO Henry McKinnell Jr. joins ViewRay's board

By Chuck Soder, Crain's Cleveland Business  |  April 12, 2016

A former Pfizer CEO now sits on ViewRay's board. Henry “Hank” McKinnell Jr. sees a lot of potential in the Oakwood Village, Ohio, company's MRI-guided radiation therapy system, according to a news release issued by ViewRay.

Commentary: Price transparency critical to success under bundled payment

Commentary: Price transparency critical to success under bundled payment

By Michael Alkire  |  April 07, 2016

Moving to bundled payment represents a sweeping change for most healthcare systems. On one hand, bundled payment poses financial risk. On the other, it offers an opportunity to crack one of the toughest nuts in healthcare cost—the world of physician preference items.

Innovation a factor in insulin drug prices tripling over past decade

By Steven Ross Johnson  |  April 05, 2016

The price of insulin, a drug that's been around for nearly a century, has been steadily rising, surpassing the cost of similar treatments and becoming an increasingly unaffordable necessity for the roughly 6 million Americans with diabetes. And in this case, innovation may be to blame.

Kellogg named president, CEO at Omron

Kellogg named president, CEO at Omron

By Katherine Davis, Crain's Chicago Business  |  March 31, 2016

Omron Healthcare, a $7 billion heart health technology manufacturer and distributor, named Ranndy Kellogg president and CEO, giving him responsibility for operations in the U.S. and Canada.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.